mDR Limited Extraordinary General Meeting: Key Highlights and Investor Insights

Overview

mDR Limited has released its responses to questions from the Securities Investors Association (Singapore) regarding its upcoming Extraordinary General Meeting (EGM) scheduled for 31 March 2026. The central topic is the company’s proposed renounceable, non-underwritten rights cum warrants issue, which has undergone multiple revisions since its initial announcement in June 2025.

Key Points Investors Must Know

• Rights Cum Warrants Issue – Revised Terms:
  • Issue price per Rights Share revised from S\$0.03 to S\$0.045.
  • Exercise price per Warrant increased from S\$0.01 to S\$0.045.
  • Provisional allotment remains at five Rights Shares for every three existing shares.
  • Warrant ratio changed from five warrants for every one Rights Share subscribed to one warrant for every one Rights Share subscribed.
  • Warrant tenure extended from 3 years to 5 years.
• Market and Regulatory Feedback:
  • The revisions were driven by direct market feedback, including increased share price and trading volume after the initial announcement.
  • SGX-ST granted approval in-principle for the listing of rights shares, warrants, and warrant shares.
  • No regulatory concerns or negative shareholder feedback on dilution or shareholder protection were cited; changes were initiated by the company based on investor appetite.
• Dilution and Economic Impact:
  • Issue and exercise prices represent substantial discounts to the prevailing share price, net asset value (NAV), and theoretical ex-rights price. For instance, the issue price is at a 30.77% discount to the 1-month VWAP and a 73.62% discount to NAV.
  • Controlling shareholder group may increase their stake from 45.78% to as high as 85.25% through a concurrent whitewash resolution.
  • The board asserts that the rights issue is offered on a pro rata basis, allowing shareholders to participate, sell, or right-size their holdings.
  • Minority shareholders can monetize nil-paid rights or mother shares before/after the ex-date, potentially mitigating economic
    
    

    View MDR Limited Historical chart here